The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies
Open accessAbstract
Obtaining reliable longitudinal information about everyday functioning from individuals with Parkinson's disease (PD) in natural environments is critical for clinical care and research. Despite advances in mobile health technologies, the implementation of digital outcome measures is hindered by a lack of consensus on the type and scope of measures, the most appropriate approach for data capture (eg, in clinic or at home), and the extraction of timely information that meets the needs of patients, clinicians, caregivers, and health care regulators. The Movement Disorder Society Task Force on Technology proposes the following objectives to facilitate the adoption of mobile health technologies: (1) identification of patient‐centered and clinically relevant digital outcomes; (2) selection criteria for device combinations that offer an acceptable benefit‐to‐burden ratio to patients and that deliver reliable, clinically relevant insights; (3) development of an accessible, scalable, and secure platform for data integration and data analytics; and (4) agreement on a pathway for approval by regulators, adoption into e‐health systems and implementation by health care organizations. We have developed a tentative roadmap that addresses these needs by providing the following deliverables: (1) results and interpretation of an online survey to define patient‐relevant endpoints, (2) agreement on the selection criteria for use of device combinations, (3) an example of an open‐source platform for integrating mobile health technology output, and (4) recommendations for assessing readiness for deployment of promising devices and algorithms suitable for regulatory approval. This concrete implementation guidance, harmonizing the collaborative endeavor among stakeholders, can improve assessments of individuals with PD, tailor symptomatic therapy, and enhance health care outcomes. © 2019 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Classification of Functioning, Disability and Health
World Health Organization (2021) · PsycTESTS Dataset · doi:10.1037/t76403-000 · Cited by 3,751
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2015) · BMJ · doi:10.1136/bmj.h5527 · Cited by 3,660
Clinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
MDS research criteria for prodromal Parkinson's disease
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G., Joseph, L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26431 · Cited by 1,309
Self-citationTechnology in Parkinson’s disease: challenges and opportunities
Espay, A. J., Bonato, P., Nahab, F. B., Maetzler, W., Dean, J. M., Klucken, J., Eskofier, B. M., Merola, A., Horak, F., Lang, A. E., et al. (2016) · Movement Disorders · doi:10.1002/mds.26642 · Cited by 654
Self-citationFrom hype to reality: data science enabling personalized medicine
Fröhlich, H., Balling, R., Beerenwinkel, N., Kohlbacher, O., Kumar, S., Lengauer, T., Maathuis, M. H., Moreau, Y., Murphy, S. A., Przytycka, T. M., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1122-7 · Cited by 414
Zhan, A., Mohan, S., Tarolli, C., Schneider, R. B., Adams, J. L., Sharma, S., Elson, M. J., Spear, K. L., Glidden, A. M., Little, M. A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0809 · Cited by 381
Self-citationLipsmeier, F., Taylor, K. I., Kilchenmann, T., Wolf, D., Scotland, A., Schjodt‐Eriksen, J., Cheng, W., Fernandez‐Garcia, I., Siebourg‐Polster, J., Jin, L., et al. (2018) · Movement Disorders · doi:10.1002/mds.27376 · Cited by 266 · cited 1×
“Digital measures derived from wearables/mobile technologies and applications are slowly starting to emerge as secondary or exploratory outcome measures in the context of clinical trials 4,12 and, to a lesser extent, as treatment targets in clinical care.”
BackgroundGodinho, C., Domingos, J., Cunha, G., Santos, A. T., Fernandes, R. M., Abreu, D., Gonçalves, N., Matthews, H., Isaacs, T., Duffen, J., et al. (2016) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-016-0136-7 · Cited by 226
Self-citationAmbulatory activity in incident Parkinson’s: more than meets the eye?
Lord, S., Godfrey, A., Galna, B., Mhiripiri, D., Burn, D., & Rochester, L. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7037-5 · Cited by 188
Self-citation
Cited by
Long-term unsupervised mobility assessment in movement disorders
Warmerdam, E., Hausdorff, J. M., Atrsaei, A., Zhou, Y., Mirelman, A., Aminian, K., Espay, A. J., Hansen, C., Evers, L. J. W., Keller, A., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30397-7 · Cited by 306
Self-citationThe Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders
Bloem, B. R., Dorsey, E. R., & Okun, M. S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1452 · Cited by 224
Self-citationMachine learning and digital biomarkers can detect early stages of neurodegenerative diseases
Chudzik, A., Śledzianowski, A., & Przybyszewski, A. W. (2024) · Sensors · doi:10.3390/s24051572 · Cited by 122
Duffy, A., Christie, G. J., & Moreno, S. (2022) · JMIR Human Factors · doi:10.2196/35693 · Cited by 114
Taylor, K. I., Staunton, H., Lipsmeier, F., Nobbs, D., & Lindemann, M. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0305-8 · Cited by 85
Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience
Godfrey, A., Vandendriessche, B., Bakker, J. P., Fitzer‐Attas, C., Gujar, N., Hobbs, M., Liu, Q., Northcott, C. A., Parks, V., Wood, W. A., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.12865 · Cited by 60
Chen, J.-F., & Schwarzschild, M. A. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.10.024 · Cited by 39
Mammen, J. R., Speck, R. M., Stebbins, G. M., Müller, M. L. T. M., Yang, P. T., Campbell, M., Cosman, J., Crawford, J. E., Dam, T., Hellsten, J., et al. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-225122 · Cited by 38
Self-citationInterpretable video-based tracking and quantification of Parkinsonism clinical motor states
Deng, D., Ostrem, J. L., Nguyen, V., Cummins, D. D., Sun, J., Pathak, A., Little, S., & Abbasi-Asl, R. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00742-x · Cited by 25
Improving anxiety in Parkinson's disease: A cautionary tale about mobile health technologies
Lingaiah, A., Mohanty, D., Marchbank, J., Jacob, A. E., Castellanos, R. L., Holiday, V., Espay, A. J., & LaFaver, K. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.03.010 · Cited by 6
Self-citation
Metadata
- Authors
- Espay, A. J., Hausdorff, J. M., Sánchez‐Ferro, Á., Klucken, J., Merola, A., Bonato, P., Paul, S. S., Horak, F. B., Vizcarra, J. A., Mestre, T. A., Reilmann, R., Nieuwboer, A., Dorsey, E. R., Rochester, L., Bloem, B. R., Maetzler, W., & on behalf of the Movement Disorder Society Task Force on Technology
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2019-03-22
- Volume
- 34
- Issue
- 5
- Pages
- 657-663
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2945893512
- Cited by
- 321
- References
- 21
- FWCI
- 47.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.